EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access · CC BY 4.0

Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens

Eunjung Jeong iD, Minhee Kang iD, Sun Ae Yun, Tae Yeul Kim iD, Hee Jae Huh iD

Microbiology Spectrum · 2026

DOI: 10.1128/spectrum.02672-25 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Eunjung Jeong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Engineering Research Center, Smart Healthcare Research Institute, Samsung Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Nasopharynx, SARS-CoV-2, Influenza A virus, Influenza B virus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SD Biosensor, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay (M10 Fast), recently CE-marked, is an updated version of the STANDARD M10 Flu/RSV/SARS-CoV-2 assay. It includes additional gene targets to improve sensitivity and coverage and reduces run time from 60 min to 36 min. This study evaluated the analytical and clinical performance of the M10 Fast assay. A total of 664 nasopharyngeal swab specimens (108 influenza A-positive, 119 influenza B-positive, 79 respiratory syncytial virus [RSV]-positive, 165 SARS-CoV-2-positive, 2 influenza A/RSV co-positive, 1 RSV/SARS-CoV-2 co-positive, and 190 negative), confirmed by the BIOFIRE Respiratory Panel 2.1 plus (RP2.1 plus ), were tested in parallel using the M10 Fast assay and the Allplex SARS-CoV-2/FluA/FluB/RSV assay (Allplex). RNA standards were serially diluted and tested with the M10 Fast assay to determine the limit of detection (LOD). Using RP2.1 plus as the reference standard, the M10 Fast assay demonstrated sensitivities of 98.2%, 100%, 95.1%, and 100% for influenza A, influenza B, RSV, and SARS-CoV-2, respectively. The Allplex assay showed sensitivities of 88.2%, 100%, 91.5%, and 100% for the same viruses. Both assays exhibited high specificity (>99%). The LODs of the M10 Fast assay were 7.8, 35.3, 532.7, 34.7, and 88.0 copies/mL for influenza A, influenza B, RSV, and SARS-CoV-2 ORF1ab/E and N genes, respectively, and were lower than previously reported Allplex LODs, except for RSV. The M10 Fast assay reliably detects influenza A and B, RSV, and SARS-CoV-2 with high sensitivity and specificity, demonstrating performance comparable to or exceeding that of the widely used Allplex assay. IMPORTANCE The STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay (M10 Fast) is an updated version of the STANDARD M10 Flu/RSV/SARS-CoV-2 assay. This study demonstrates that the M10 Fast assay reliably detects influenza A and B, respiratory syncytial virus (RSV), and SARS-CoV-2 with high sensitivity and specificity, including improved detection at low viral loads. Its enhanced performance and shorter turnaround time support timely clinical decision-making and strengthen public health responses, particularly during periods of cocirculation of influenza, RSV, and SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NasopharynxSARS-CoV-2Influenza A virusInfluenza B virusInfluenza, HumanRespiratory Syncytial Virus InfectionsCOVID-19Respiratory Syncytial VirusesHumansSensitivity and SpecificityRespiratory Syncytial Virus, HumanRapid Diagnostic Tests

Stichwörter der Autor:innen

AllplexM10 fastRSVSARS-CoV-2evaluationinfluenza

Autor:innen und Institutionen

  • Biomedical Engineering Research Center, Smart Healthcare Research Institute, Samsung Medical Center, Seoul, Republic of Korea.
  • Research Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea.
  • Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Department of Medical Device Management and Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Republic of Korea.

ORCID-Profile: Eunjung Jeong, Minhee Kang, Tae Yeul Kim, Hee Jae Huh

Förderung

  • SD Biosensor
  • Korea Health Industry Development Institute

Zitieren

APA

Jeong, E., Kang, M., Yun, S. A., Kim, T. Y., & Huh, H. J. (2026). Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens. Microbiology Spectrum. https://doi.org/10.1128/spectrum.02672-25

Vancouver

Jeong E, Kang M, Yun SA, Kim TY, Huh HJ. Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens. Microbiology Spectrum. 2026. doi:10.1128/spectrum.02672-25

BibTeX
@article{Jeong2026,
  author = {Jeong, Eunjung and Kang, Minhee and Yun, Sun Ae and Kim, Tae Yeul and Huh, Hee Jae},
  title = {Evaluation of the STANDARD M10 Flu/RSV/SARS-CoV-2 Fast assay for the detection of influenza A/B viruses, respiratory syncytial virus, and SARS-CoV-2 in nasopharyngeal swab specimens},
  journal = {Microbiology Spectrum},
  year = {2026},
  doi = {10.1128/spectrum.02672-25}
}
Kostenlos starten →